TELA Bio, Inc.
TELA· Nasdaq
TELATELA Bio, Inc.
Filed Aug 13, 2020 · 10-Q · 44 days after period end · 0001558370-20-010570
| Metric | Q2 2020 | Q2 2019 |
|---|---|---|
| Revenue | $3.51M | $3.30M |
| Net Income | -$6.08M | -$5.26M |
| EPS Diluted | -$0.53 | -$27.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TELA Bio, Inc. · CIK 1561921 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Aug 13, 2020 · 44 d after period end
